Gelder Mark S. MD 4
4 · Onconova Therapeutics, Inc. · Filed Aug 4, 2021
Insider Transaction Report
Form 4
Gelder Mark S. MD
CHIEF MEDICAL OFFICER
Transactions
- Award
Stock Option (right to purchase)
[F1]2021-08-02+41,825→ 41,825 totalExercise: $5.19Exp: 2031-08-02→ Common stock (41,825 underlying) - Award
Restricted Stock Units
[F3][F2]2021-08-02+13,950→ 13,950 total→ Common stock (13,950 underlying)
Footnotes (3)
- [F1]These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years.
- [F2]These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary.
- [F3]Each restricted stock unit is convertible into one share of common stock.
Signature
/s/ Mark Guerin as attorney-in-fact|2021-08-04